Biomarker Testing Market Expected to Reach Billion by 2030 with a CAGR of

Biomarker Testing Market Share

The Business Research Company

The Business Research Company’s Biomarker Testing Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035

LONDON, GREATER LONDON, UNITED KINGDOM, November 6, 2026 /EINPresswire.com/ -- The biomarker testing market has been witnessing remarkable growth, driven by advancements in medical diagnostics and rising healthcare demands. As personalized medicine and targeted therapies gain momentum, the industry is poised for substantial expansion over the coming years. Below is an overview of the market’s size, key growth drivers, regional outlook, and emerging trends shaping its trajectory.

Biomarker Testing Market Size and Projected Growth
The biomarker testing market has experienced swift growth in recent years. It is anticipated to increase from $19.75 billion in 2025 to $22.26 billion in 2026, reflecting a strong compound annual growth rate (CAGR) of 12.7%. This historical expansion has been fueled by factors such as the rising prevalence of chronic diseases, the broadening scope of clinical research, heightened adoption of molecular diagnostic techniques, increased demand for targeted therapies, and the availability of sophisticated testing platforms.

Download a free sample of the biomarker testing market report:
https://thebusinessresearchcompany.com/sample_request?id=61973212&type=smp&name=Biomarker%20Testing%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR

Looking ahead, the market is expected to continue its rapid ascent, growing to $35.51 billion by 2030 at a CAGR of 12.4%. This forecasted growth is supported by growing investments in personalized medicine, enhanced use of biomarkers throughout drug development processes, expansion in oncology and infectious disease testing, a rising preference for minimally invasive diagnostic methods, and technological progress in multi-omics platforms. Key trends anticipated during this period include broader acceptance of precision medicine diagnostics, greater application of companion diagnostics, increased integration of artificial intelligence in biomarker analysis, expansion of liquid biopsy techniques, and a stronger focus on early disease detection.

Understanding Biomarker Testing and Its Importance
Biomarker testing involves analyzing blood, tissue, or other bodily fluids to detect specific biological markers that indicate normal or pathological states. This testing plays an essential role in diagnosing diseases, forecasting disease progression, and customizing treatment plans to individual patients, improving outcomes and healthcare efficiency.

View the full biomarker testing market report:
https://thebusinessresearchcompany.com/report/biomarker-testing-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR

Cancer Burden as a Major Growth Driver in the Biomarker Testing Market
A significant factor propelling the biomarker testing market is the growing cancer burden worldwide. Cancer comprises a group of diseases marked by uncontrolled abnormal cell growth and spread. The increase in cancer cases is linked to lifestyle factors such as poor diet, smoking, lack of physical activity, and excessive alcohol use. Biomarker testing enhances cancer care by enabling early and accurate identification of disease-specific markers, which improves diagnostic precision and supports personalized therapy plans, leading to better patient management.

For example, in July 2024, the Australian Institute of Health and Welfare reported that approximately 165,000 new cancer cases were diagnosed in Australia in 2023. Projections estimate this number will rise to about 204,000 annually by 2033, totaling around 1.9 million cases from 2024 to 2033. This escalating cancer incidence is a key factor driving demand for biomarker testing solutions globally.

Regional Growth Outlook in the Biomarker Testing Market
In 2025, North America held the largest share of the biomarker testing market, reflecting its advanced healthcare infrastructure and extensive research activities. Meanwhile, the Asia-Pacific region is forecasted to experience the fastest growth over the coming years, driven by increasing healthcare investments, expanding diagnostic capabilities, and rising awareness about personalized medicine. The market report covers various regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive global perspective on market dynamics.

New additions to our 2026 reports:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X